Achievement

The 1^st publicly traded company specializing in genetic diagnosis and scientific informatics in Taiwan with its IPO (4160-TW) in 2012.
The 1^st to successfully introduce Spinal Muscular Atrophy Carrier Testing (SMA), Maternal Serum Down Syndrome Screening Test (SDS), Pre-implantation Genetic Diagnosis (PGD), UltraPGD, Pre-implantation Genetic Screening (PGS) and Next-Generation Sequencing (NGS)-based PGS into the Taiwan market.
The 1^st laboratory in Taiwan to be accredited by the College of American Pathologists (CAP) and Taiwan Accreditation Foundation (TAF), as well as granted Affymetrix® Service Provider and Illumina® CSPro certificate.

Serving around 50% of newborn babies every year in Taiwan
Expanding overseas business successfully by providing genetic testing services in Asia, Europe and the Americas
Establishing a Genetic Counseling Team, a first in the industry, to deliver expert genetic support to the clients
Building a complete platform of global standard for genetic testing with state-of-the-art laboratory facilities and equipment including next-generation sequencing and single nucleotide polymorphism (SNP) microarray devices

The 1^st biotech company in Taiwan with a full-fledged informatics business unit, Molecular Science Center (MSC), whose solutions and services span bioinformatics, life sciences, materials sciences, and enterprise laboratory and quality management.
Named Deloitte’s Technology Fast 500 Asia Pacific Companies in 2012 & 2013 for its revenue growth over the 3-year period.